Avulux and BluTech announced in a press release a direct partnership under which BluTech will manufacture the next generation of Avulux migraine and light-sensitivity lenses. These lenses replace the current generation of Avulux lenses as of January 5, 2026. 

According to the press release, the next generation of Avulux lenses will leverage BluTech’s proprietary lens composition to improve Abbe value from 29 to 38, resulting in clearer, sharper vision with less color fringing or blur, improved contrast, and reduced eye strain.

In addition, the press release notes that the new generation of Avulux lenses will feature an improved cosmetic appearance and better color consistency from lens to lens, regardless of geometry, thickness, material, or other factors.

Further, these lenses will have high heat tolerances that can withstand virtually all lab processes—allowing Avulux lenses to be more compatible with a wide range of coatings, according to the press release.

Avulux and BluTech have also begun work on both a polarized and photochromic lens, both of which are anticipated to be available in the second quarter of 2026, according to the press release. OM